share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer BOURLA ALBERT

Pfizer | 4: Statement of changes in beneficial ownership of securities

辉瑞 | 4:持股变动声明
美股SEC公告 ·  04/11 14:55
Moomoo AI 已提取核心信息
Pfizer Inc. (PFE) Chairman & CEO Albert Bourla executed a transaction of non-derivative securities on April 10, 2024. The specific details of the transaction, including the number of shares, transaction price, and total value, were not disclosed in the announcement. Bourla's relationship with the company as Chairman & CEO places him in a position of significant influence, and such transactions are closely watched by investors for indications of executive confidence in the company's performance and outlook.
Pfizer Inc. (PFE) Chairman & CEO Albert Bourla executed a transaction of non-derivative securities on April 10, 2024. The specific details of the transaction, including the number of shares, transaction price, and total value, were not disclosed in the announcement. Bourla's relationship with the company as Chairman & CEO places him in a position of significant influence, and such transactions are closely watched by investors for indications of executive confidence in the company's performance and outlook.
辉瑞公司(PFE)董事长兼首席执行官阿尔伯特·布尔拉于2024年4月10日执行了一笔非衍生证券交易。公告中未披露该交易的具体细节,包括股票数量、交易价格和总价值。Bourla作为董事长兼首席执行官与公司的关系使他处于重要的影响力,此类交易受到投资者的密切关注,以寻找高管对公司业绩和前景充满信心的迹象。
辉瑞公司(PFE)董事长兼首席执行官阿尔伯特·布尔拉于2024年4月10日执行了一笔非衍生证券交易。公告中未披露该交易的具体细节,包括股票数量、交易价格和总价值。Bourla作为董事长兼首席执行官与公司的关系使他处于重要的影响力,此类交易受到投资者的密切关注,以寻找高管对公司业绩和前景充满信心的迹象。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息